Guidelines and recent publications

The BGCS has produced a framework for the care of women with gynaecological cancer during the COVID 19 pandemic.

BGCS framework for care of patients with gynaecological cancer during the COVID-19 Pandemic

The BGCS has produced this framework for the care of women with gynaecological cancer during the COVID 19 pandemic.  

The document was produced by a multidisciplinary team comprising gynaecological oncologists, clinical oncologists, medical oncologists and clinical nurse specialists.  

BGCS working group on COVID 19:

Chair – Sudha Sundar 

Team – Nick Wood, Sadaf Ghaem-Maghami, Christina Fotopoulou, Jo Morrison, Rick Clayton, Jonathan Ledermann, Aggie Michael, Andy Nordin, Rebecca Bowen, Sarah Williams, Alex Taylor, Dennis Yiannakis, Bruce Ramsay, Helen Manderville, Tracie Miles. 

View Document

RCOG BSGE BGCS guidance on Abnormal uterine bleeding in the COVID-19 pandemic

The guidance encompasses commissioners, primary care and secondary care.

View Document

The Cervix cancer and Vulval cancer guidelines are currently being developed and will be available shortly.

We plan an update of both the Endometrial cancer and Ovarian cancer guidelines in 2020.

View Uterine Cancer Guidelines

View Ovarian Cancer Guidelines

The society has also launched the first Sentinel LN consensus document available here which is planned to be also submitted in a peer reviewed journal.

NCRAS cervical cancer radical hysterectomy analysis

Please see the executive summary paper from NCRAS summarising the findings of the analysis of MAS v open radical hysterectomy in England for cervical cancer 2013-16. The BGCS guidance statements for professionals and the public are also posted on this site. A formal peer review publication by NCRAS and BGCS officers will follow in due course.

View NCRAS summary paper
View BGCS professionals statement
View BGCS lay statement

Consensus document on risk stratified follow up pathways in the management of ovarian, cervical, endometrial and vulval malignancies

The BGCS is pleased to present a consensus document on risk-stratified follow-up pathways in the management of ovarian, cervical, endometrial and vulval malignancies. The statement reflects an analysis of the published evidence assessing the evidence for modernised, alternative follow-up strategies, combined with review of expert opinion and experience, in order to achieve specialist consensus. The statement will inform forthcoming BGCS clinical guidelines for the management of these diseases, and we hope that they will also inform future NHS England Specialist Commissioning specifications and commissioning guidelines from the NHS in Scotland, Wales and Northern Ireland.

We would like to thank the specialist working group for the time and effort which went into developing this document, and particularly Christina Fotopoulou, Chair of the BGCS Guidelines Subgroup for leading the process.

Sudha Sundar, BGCS President
Andy Nordin
, BGCS Past President

View document

Sentinel Consensus Document for Vulval, Endometrial and Cervical Cancer BGCS

The BGCS is pleased to present these consensus statements on the use of sentinel lymph node staging in the management of cervical, endometrial and vulval malignancies. The statement reflects an analysis of the published evidence assessing this methodology combined with review of expert opinion and experience, and involved a formal “Delphi” process to achieve specialist consensus. The statement will inform forthcoming BGCS clinical guidelines for the management of these diseases, and we hope that they will also inform future NHS England Specialist Commissioning specifications and commissioning guidelines from the NHS in Scotland, Wales and Northern Ireland.

We would like to thank the specialist working group for the time and effort which went into developing these consensus statements, and particularly Christina Fotopoulou, Chair of the BGCS Guidelines Subgroup for leading the process.

View document